At a glance
ClinicalIndex Comparison RecordN/ACompleted· 48 enrolled
Drug / intervention
ClearVoicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the ClearVoice™ Strategy in Adults Using HiResolution® Fidelity 120® Sound Processing
In Brief
A clinical study evaluating ClearVoice for Implant. Completed, enrolled 48 participants across 11 sites in 2 countries.
Detailed Summary
The purpose of this study is to collect information about how the new sound-processing affects the ability to hear in everyday listening situations.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsImplant
CountriesCanada, United States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2010
Enrollment StartMar 2010
Primary CompletionSep 2010
TodayJul 2026
First PostedFeb 10, 2010
Enrollment StartMar 1, 2010
Primary CompletionSep 1, 2010
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 16.4 years ago
Interventions
ClearVoicedevice
ClearVoice is a sound processing strategy designed to improve listening ability in some challenging everyday listening environments for users of the Harmony® HiResolution® Bionic Ear System (Harmony®)